REGENXBIO Inc. (RGNX) — Stock Score Summary

REGENXBIO Inc. (RGNX) has a MoatMap StockRank of 1/100 based on Quality (13/100), Value (33/100), and Momentum (20/100) factor scores. The current signal is STRONG SELL. A clinical-stage biotechnology company focused on gene therapies. It lacks the commercial-stage cash flows, pricing power, or validated manufacturing scale of a high-quality CDMO, making it too speculative for our concentrated book.

REGENXBIO Inc. is a leading clinical-stage biotechnology company focused on the development of gene therapies using its proprietary NAV® AAV gene delivery platform. The company's pipeline targets severe genetic diseases across ophthalmology, neurodegenerative diseases, and other therapeutic areas, with multiple programs in clinical development. REGENXBIO maintains a strong competitive moat through its extensive patent estate and broad licensing strategy for its advanced gene delivery technology.

Key Financial Metrics

Price$6.69
Market Cap$356M
P/E (Forward)-2.50
Price/Book15.47
Return on Equity-196.4%
Return on Invested Capital-44.4%
Debt/Equity1178.24
Gross Margin-196.6%
Operating Margin-1304.0%
Revenue Growth-92.8%
Free Cash Flow$-139M

REGENXBIO Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is REGENXBIO Inc.’s (RGNX) StockRank?
MoatMap’s StockRank for REGENXBIO Inc. (RGNX) is 1/100, with a Strong Sell signal. It is a composite of Quality (13), Value (33), and Momentum (20) factor ranks across MoatMap’s 19,000+ stock universe.
Does REGENXBIO Inc. have an economic moat?
REGENXBIO Inc. (RGNX) has a Quality factor score of 13/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is REGENXBIO Inc. a buy, hold, or sell?
MoatMap’s current signal for REGENXBIO Inc. (RGNX) is Strong Sell, based on a StockRank of 1/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is REGENXBIO Inc. in?
REGENXBIO Inc. (RGNX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksRGNX deep dive reportAI ChampionsHow we score stocksSense-check another stock